Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Psilocybin program
Recent news which mentions Psilocybin program
< Previous
1
2
Next >
Compass' Psilocybin Therapy Proves Helpful In Treating Anorexia: Clinical Trial Shows
July 25, 2023
Tickers
CMPS
Tags
Markets
Market News
Cannabis
From
Benzinga
Cybin, Bright Minds And PharmAla: A Short Recap On Progress Within Clinical Trials
July 24, 2023
Tickers
CYBN
DRUG
PMBHF
Tags
Markets
Market News
Cannabis
From
Benzinga
Filament Health Uplisting To NASDAQ In A $210M SPAC Deal
July 19, 2023
Tickers
FLHLF
JAQC
Tags
Psilocybin program
JAQC
Benzinga
From
Benzinga
Compatibility Of Psilocybin & SSRIs For Depression, COMPASS Looks At 'Psychedelic-Assisted Therapies'
July 18, 2023
Tickers
CMPS
Tags
treatment/resistant depression
Markets
Market News
From
Benzinga
Filament Supplies Botanical Psilocybin To Canadian Researchers, Inks Global Licensing Deal
July 07, 2023
Tickers
FLHLF
Tags
Psilocybin program
Psychedelics
Licensing Deal
From
Benzinga
Wesana Shareholders Vote For Psilocybin And CBD Therapy Asset Sales To Lucy Scientific
June 12, 2023
Tickers
LSDI
WSNAF
Tags
Contracts
LSDI
Markets
From
Benzinga
From The U.S. To Canada: High-Quality Psilocybin API Gets Green Light For Import
June 12, 2023
Tags
Global
Market News
Cannabis
From
Benzinga
Creso Pharma's LOI For Import Of Swiss MDMA And Psilocybin Therapeutics To Australia
June 09, 2023
Tickers
COPHF
MNMD
Tags
MNMD
COPHF
Psychedelics
From
Benzinga
Colorado Media Buzz On Psychedelic Mushroom Businesses, This Company Offers 'Top Rare' Strains
June 02, 2023
Tags
Psilocybin program
Psychedelics
Benzinga
From
Benzinga
UCSF Clinical Trial Shows Promising Results For Naturally-Sourced Psilocybin And Psilocin
May 30, 2023
Tickers
FLHLF
Tags
University of California San Francisco
News
Penny Stocks
From
Benzinga
Numinus' Clinical Site Joins Compass' Phase 3 Program On Psilocybin Therapy For TRD
May 30, 2023
Tickers
CMPS
NUMIF
Tags
Small Cap
CMPS
Psychedelic/Assisted Therapies
From
Benzinga
Washington State Psychedelics Trial Targets PTSD And Alcohol Use Disorder, Mandated By Law
May 23, 2023
Tags
Cannabis
Market News
Psychedelics Reform
From
Benzinga
Link Between Cancer And Psilocybin: Research On This Palliative Promise
May 22, 2023
Tickers
CMPS
Tags
News
Benzinga
Psychedelics
From
Benzinga
This Biotech Company Discovers What May Be The First New Compounds Of Psilocybin In History
May 19, 2023
Tags
WIPO
FDA
Psychedelic/Assisted Therapies
From
Benzinga
EXCLUSIVE: Lessons From Psychedelics Markets Through Business, Legal And Reciprocity Lenses
May 12, 2023
Tickers
BWVI
Tags
Exclusives
Events
News
From
Benzinga
COMPASS Pathways Reports Q1 2023: Financials, Commercial Groundwork And Ongoing Phase 3 Trials
May 11, 2023
Tickers
CMPS
Tags
Earnings
American Medical Association
News
From
Benzinga
International IP Claims On Novel Psychedelic Fungi Biomass Manufacturing Gets Prelim Acceptance
May 03, 2023
Tags
Albert Labs
News
Psilocybin program
From
Benzinga
Psyched: Canada's Case For Psilocybin Access And Microdose Trial, US Reform Update, Battle With DEA & More
April 05, 2023
Tickers
IGXT
NUMIF
PHRRF
RVVTF
Tags
PHRRF
Psychedelics Reform
RVVTF
From
Benzinga
Therapists At Mass General Hospital Prepared To Assist IBS Patients With Psilocybin Therapy
April 04, 2023
Tickers
TRYPF
Tags
Psilocybin program
Penny Stocks
Psychedelics
From
Benzinga
Filament Health: 2022 Financials And Operational Highlights From Creator Of The Ayahuasca Pill
April 03, 2023
Tickers
FLHLF
JAGX
Tags
Psychedelic/Assisted Therapies
Management
JAGX
From
Benzinga
COMPASS Pathways: New Data & Insight On Psilocybin Therapy For Treatment-Resistant Depression
March 14, 2023
Tickers
CMPS
Tags
Benzinga
Psychedelics
Psilocybin program
From
Benzinga
Australia Receives First Batch Of Clinical-Grade Psilocybin From Mindset Pharma And PharmAla
March 06, 2023
Tickers
MSSTF
OPTHF
Tags
Cannabis
OPTHF
Market News
From
Benzinga
COMPASS Pathways Shares Q4 & Year-End 2022 Financials, Advances Phase 3 Psilocybin Trials
February 28, 2023
Tickers
CMPS
Tags
Small Cap
CMPS
Psychedelic/Assisted Therapies
From
Benzinga
2C-B Vs. Psilocybin: New Study Shares Insightful Trial Results On The Mescaline-Derived Psychedelic's Effects
February 21, 2023
Tags
General
Psychedelic/Assisted Therapies
Psychedelics
From
Benzinga
State-Level Psychedelics In 2023: Oklahoma Introduces Research Bill, Washington Amends And Passes Measure
February 17, 2023
Tags
Psychedelics Legalization
Government
Psilocybin program
From
Benzinga
Supply Partnerships: Filament's Psilocybin Trial In Canada, PharmAla's MDMA Program In Australia
February 14, 2023
Tickers
FLHLF
Tags
Legal
Management
PharmAla Biotech Holdings Inc
From
Benzinga
Health Canada Grants Exemption: Phase 2 Trial On Psilocybin For Genetic Disorder
February 14, 2023
Tickers
KONEF
NMLSF
Tags
Market News
Cannabis
KGK Sciences
From
Benzinga
Psyched: 12 States Discuss Legalization Bills, Ceremonies For Veterans With TBI, Ketamine And MDMA Fast-Tracks & More
February 13, 2023
Tickers
AWKNF
NUMIF
OPTHF
PHRRF
Tags
NUMIF
Penny Stocks
Guidance
From
Benzinga
Testing Psychedelics Efficacy On 'Psychiatry's Blind Spot': Latest King's College Trial
February 13, 2023
Tags
Psychedelics
Benzinga
Psilocybin program
From
Benzinga
How Do Psilocybin And MDMA Work Together? This Proposed Experiential Study Is Set To Find Out
February 09, 2023
Tickers
OPTHF
Tags
Markets
Market News
Cannabis
From
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.